SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SHAMAN PHARMACETICALS - SHMN - U.S. OTC -- Ignore unavailable to you. Want to Upgrade?

To: Mike Jafari who wrote (59)8/5/1998 11:41:00 PM
From: Matthew Calvert  Read Replies (1) | Respond to of 69
 
I read the same article and wasn't sure how to take the reference to Shaman. It says T Rowe Price sold the good with the bad and that hurt the price of those in which the fund was a major shareholder. I'd like to think that they meant that Shaman was among "the good," but I'm not sure that's what he said. Do you read this as a recommendation?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News